Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Conditions: survodutide · 5 mg/mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so I…
The particulars: a wine cooler · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
What I am working with: SURMOUNT-OSA · 10 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The case in front of me: 10 mg · 2.5 mL · 0.9% sodium chloride · mazdutide. I want to decide this in advance so that I am not deciding it under pressure later. Assume…
The specifics, since they change the answer: 10 mg · ten weeks · reflux. I understand the observation; what I do not understand is the mechanism behind it. I have…
What I am working with: tirzepatide · three weeks · room temperature. I understand the observation; what I do not understand is the mechanism behind it. I have read…
The method section is present, which is unusual enough that I want to make use of it. I have read the primary source rather than the summary, which has left me with…
I would like to know how much of this is established and how much is a reasonable story. I can find plenty of assertions about this and almost no reasoning, which is…
What I have: 95.2% · list of related substances. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
The specifics, since they change the answer: 15 mg · 5 mL · phosphate-buffered diluent · dulaglutide. I would like to define my thresholds before I have a result, for…
The particulars: oral semaglutide · ten weeks · 25 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I…
For reference: Hangzhou · the Netherlands. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
What I am working with: mazdutide · sixteen weeks · room temperature. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if…
Numbers first: cagrilintide · 1 mg/mL. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
The specifics, since they change the answer: SURMOUNT-1 · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
I have the full paper rather than the abstract, and the supplementary appendix. I can predict the outcome but I cannot explain it, which means I will get the next…
What I have: a GLP-1 receptor agonist · five days. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary;…
What I have: ecnoglutide · sterile water for injection. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
The case in front of me: FGP · Hangzhou · the Netherlands. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
Setup, so nobody has to ask: mazdutide · purity figure. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
The particulars: SUSTAIN-6 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: oral semaglutide · minus 20 °C · fourteen days. I am at the decision point and I would rather think it through than improvise. I would rather spend…
Numbers first: STEP 4 · semaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists…
Setup, so nobody has to ask: Janoshik · 98.2%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…